Patent AT-E399554-T1: [Translated] PHARMACEUTICAL COMPOSITION CONTAINING TADALAFIL
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Formulations containing a PDE5 inhibitor, a water-soluble diluent, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use in treating sexual dysfunction.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E399554-T1: [Translated] PHARMACEUTICAL COMPOSITION CONTAINING TADALAFIL on the official website.
Modified Apr 29, 2026